This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
This article has been retracted at the request of the Editors-in-Chief, because an investigation by Harvard Medical School and the Brigham and Women’s Hospital has concluded that Figure 3 is invalid and no underlying research data are available to resolve the discrepancies or validate the reported results.
Published online: February 11, 2023
© 2023 Elsevier Inc. All rights reserved.
ScienceDirectAccess this article on ScienceDirect
- Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activitySurgeryVol. 136Issue 3
- PreviewOverexpression of the facilitative glucose transporter-1 (GLUT-1) has been observed for a wide range of human cancers, with the degree of overexpression generally being inversely correlated with prognosis. We tested the effects of modulating GLUT-1 expression on pancreatic cancer cellular invasiveness.